odan-pilocarpine solution
odan laboratories ltd - pilocarpine hydrochloride - solution - 4% - pilocarpine hydrochloride 4% - miotics
pms-pilocarpine 0.5% liquid
pharmascience inc - pilocarpine hydrochloride - liquid - 5mg - pilocarpine hydrochloride 5mg - miotics
pms-pilocarpine 1% liquid
pharmascience inc - pilocarpine hydrochloride - liquid - 10mg - pilocarpine hydrochloride 10mg - miotics
pms-pilocarpine 2% liquid
pharmascience inc - pilocarpine hydrochloride - liquid - 20mg - pilocarpine hydrochloride 20mg - miotics
pms-pilocarpine 4% liquid
pharmascience inc - pilocarpine hydrochloride - liquid - 40mg - pilocarpine hydrochloride 40mg - miotics
pms-pilocarpine 6% liquid
pharmascience inc - pilocarpine hydrochloride - liquid - 60mg - pilocarpine hydrochloride 60mg - miotics
pilocarpine eye drops 2.0% w/v
macarthys laboratories limited bampton road, harold hill, romford essex, rm3 8ug, united kingdom - pilocarpine hydrochloride - eye drops - pilocarpine hydrochloride 20 mg/ml - ophthalmologicals
pilocarpine eye drops 1.0% w/v
macarthys laboratories limited bampton road, harold hill, romford essex, rm3 8ug, united kingdom - pilocarpine hydrochloride - eye drops - pilocarpine hydrochloride 1 % (w/v) - ophthalmologicals
pilocarpine eye drops 4.0% w/v
macarthys laboratories limited bampton road, harold hill, romford essex, rm3 8ug, united kingdom - pilocarpine hydrochloride - eye drops - pilocarpine hydrochloride 4 % (w/v) - ophthalmologicals
pilocarpine hydrochloride tablet, film coated
bryant ranch prepack - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride tablets, usp are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with sjogren's syndrome. pilocarpine hydrochloride tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.